Aripiprazole Improved Post-Streptococcal Dyskinesia by Modulating Dopaminergic Activity: A Case Report
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Psychopharmacology and Neuroscience"
DOI: 10.9758/cpn.2022.20.3.581
Abstract: This case report aimed to discuss the efficacy of aripiprazole for dyskinesia in patients with functional movement disorder after streptococcal infection, with its biological action of modulating dopamine hyperactivity in the basal ganglia as a… read more here.
Keywords: aripiprazole improved; dyskinesia; report; case report ... See more keywords